Liver/Biliary Disorders News

The FDA has approved labeling changes for Livmarli, reducing the age of prescribing to infants with Alagille syndrome from 1 year to 3 months for the treatment of cholestatic pruritus, according to a Mirum Pharmaceuticals press release.

Patients diagnosed with COVID-19 during the first 3 months of the pandemic had a twofold higher risk for developing alcohol use disorder, likely driven by anxiety and fear surrounding the pandemic, according to new research.

The CDC has updated its guidance for hepatitis B testing for the first time since 2008 and now recommends that all adults in the U.S. be tested for HBV at least once in their lifetime.

Hospitals that performed at least 25 major hepatectomies per year had lower rates of postoperative in-hospital mortality and failure to rescue, suggesting better management of postoperative complications.

Physically active patients with nonalcoholic fatty liver disease were more likely to achieve at least a 30% reduction in MRI-measured liver fat, according to research in The American Journal of Gastroenterology.

Patients with hepatocellular carcinoma carried a “significantly higher” cancer-related financial burden compared with those with cirrhosis, according to data published in Clinical Gastroenterology and Hepatology.

A new ACG clinical guideline provides evidence-based recommendations for the diagnosis and management of patients with extrahepatic and perihilar biliary strictures, according to a report in The American Journal of Gastroenterology.

A machine learning model may aid the detection and classification of tertiary lymphoid structures associated with gastrointestinal cancers based on routine tissue slides, according to research in JAMA Network Open.

I never would have thought the debate on nonalcoholic fatty liver disease nomenclature would be as contentious as it is.

This exercise about nonalcoholic fatty liver disease nomenclature is a distraction from what patients really care about.